科瑞技術(002957.SZ):擬使用募集資金向惠州科瑞增資及提供借款以實施募投項目
格隆匯3月11日丨科瑞技術(002957.SZ)公佈,公司於2025年3月11日召開第四屆董事會第十八次會議、第四屆監事會第十四次會議審議通過了《關於使用募集資金向全資子公司增資及提供借款以實施募投項目的議案》,同意公司使用募集資金6,000.00萬元向全資子公司惠州市科瑞新能源裝備有限公司(簡稱“惠州科瑞”)增資,同時使用剩餘募集資金人民幣4,578.30萬元及利息和理財收益向惠州科瑞提供借款以實施募投項目。公司根據該募投項目的建設進展和實際資金需求,在上述借款總額範圍內一次或分期向惠州科瑞提供借款,借款期限五年,借款期限自實際借款之日起算。借款到期後,經批准可滾動使用,也可提前償還。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.